KurmaPartners(@KurmaPartners) 's Twitter Profileg
KurmaPartners

@KurmaPartners

Founded in July 2009, Kurma Partners is a key European player in the financing of Innovation in Healthcare and Biotechnology, from pre-seed to growth capital;

ID:937616977094500353

linkhttp://www.kurmapartners.com calendar_today04-12-2017 09:38:02

35 Tweets

318 Followers

73 Following

Jeff Cranmer(@jeff_cranmer) 's Twitter Profile Photo

.KurmaPartners' new Munich office bears 1st fruit, Max Planck spinout Tacalyx, helmed by Shire, Baxalta vet Peter Sondermann BioCentury's @iBonanos reports: biocentury.com/biocentury/fin…

account_circle
[iito] Life Science(@iitoLifeScience) 's Twitter Profile Photo

HTGF: Tacalyx Raises €7m in Seed Funding to Generate First in Class Anti-TACA Antibodies for Cancer Treatment high-tech-gruenderfonds.de/en/tacalyx-rai… HTGF Boehringer Ingelheim KurmaPartners Creathor Ventures More German life science business news at [LSG] at life-sciences-germany.com/news/Life-Scie…

HTGF: Tacalyx Raises €7m in Seed Funding to Generate First in Class Anti-TACA Antibodies for Cancer Treatment high-tech-gruenderfonds.de/en/tacalyx-rai… @HTGF @Boehringer @KurmaPartners @creathorventure #Tacalyx More German life science business news at [LSG] at life-sciences-germany.com/news/Life-Scie…
account_circle
Erganeo(@Erganeo) 's Twitter Profile Photo

🚀Erganeo helps launch start-up Ermium Therapeutics, which has already raised €6.3m in capital : erganeo.com/en/Ermium_rais…

@DOMAINTherapeut KurmaPartners Eurazeo Investment Manager
A project CNRS Innovation @UParisDescartes Erganeo

Réseau SATT

🚀Erganeo helps launch start-up Ermium Therapeutics, which has already raised €6.3m in #startup capital : erganeo.com/en/Ermium_rais… #health #diseases #immunomodulators @DOMAINTherapeut @KurmaPartners @idinvest A project @cnrsinnovation @UParisDescartes @Erganeo @ReseauSATT
account_circle
KurmaPartners(@KurmaPartners) 's Twitter Profile Photo

We are happy to announce the launch of our Munich operations headed by newlyappointed Partner Peter Neubeck.

Read the PR here

…rtners-website-backend.cdn.prismic.io/kurma-partners…

account_circle
[iito] Life Science(@iitoLifeScience) 's Twitter Profile Photo

Kurma Partners Announces First Closing of
Kurma Biofund III; Targets €150m servier.com/en/communique/… KurmaPartners @servier More French life science business news at [LSE] at Life-Sciences-Europe.com/news/life-scie…

Kurma Partners Announces First Closing of Kurma Biofund III; Targets €150m servier.com/en/communique/… @KurmaPartners @servier More French life science business news at [LSE] at Life-Sciences-Europe.com/news/life-scie…
account_circle
BioCentury(@BioCentury) 's Twitter Profile Photo

Spreading good Kurma: How KurmaPartners is expanding its preseed partnership approach beyond France, rare diseases with its €150 Biofund III buff.ly/2Bi6hzF

account_circle
Muscular Dystrophy UK(@MDUK_News) 's Twitter Profile Photo

We’re pleased to let you know that UCL Queen Square Institute of Neurology is recruiting people with Inclusion Body Myositis (IBM) to take part in the @Orphazyme_AS clinical trial. Find out how you can take part here: qoo.ly/rp58v

We’re pleased to let you know that @UCLIoN is recruiting people with Inclusion Body Myositis (IBM) to take part in the @Orphazyme_AS clinical trial. Find out how you can take part here: qoo.ly/rp58v
account_circle
Myotubular Trust(@myotubulartrust) 's Twitter Profile Photo

Great news from Dynacure today on the path to ASO clinical trials for centronuclear myopathy. We are delighted to have been part of the journey to fund research into DNM2 down regulation. With thanks as ever to all of our great supporters who make such research possible x.com/dynacure/statu…

account_circle
Xeltis(@Xeltis) 's Twitter Profile Photo

Delighted to be included in Silicon Republic's '12 innovative European medtech start-ups to watch'; learn more about how we are naturally restoring the heart valve here: Xeltis.com/technology x.com/siliconrepubli…

account_circle
Xeltis(@Xeltis) 's Twitter Profile Photo

For the first time, preliminary 1-year data from 3 patients implanted with Xeltis’ restorative pulmonary will be presented at ECHSA by Prof. Tomasz Mroczek’s on June 1. xeltis.com/news

For the first time, preliminary 1-year data from 3 patients implanted with Xeltis’ restorative pulmonary #heartvalve will be presented at @echsa_assoc by Prof. Tomasz Mroczek’s on June 1. xeltis.com/news #ECHSA2018 #1in100 #RVOT #CHDaware
account_circle
Xeltis(@Xeltis) 's Twitter Profile Photo

Xeltis’ restorative heart valves will be in the spotlight at @ICTEHV in Amsterdam on May 18. Professor FJ Schoen, @HarvardMed and CTO Martijn Cox will provide insights on the technology and on preclinical data. xeltis.com/news

Xeltis’ restorative heart valves will be in the spotlight at @ICTEHV in Amsterdam on May 18. Professor FJ Schoen, @HarvardMed and CTO @martijncox will provide insights on the technology and on preclinical data. xeltis.com/news #RVOT #ICTEHV #innovation #medtech
account_circle
Xeltis(@Xeltis) 's Twitter Profile Photo

“We are proud to be among the last finalists for this high-profile award. This accolade recognizes the potential of our restorative device to make a difference in the lives of children born with congenital heart disease,” said Xeltis CEO @lgrandidier_ xeltis.com/news/

account_circle
Xeltis(@Xeltis) 's Twitter Profile Photo

Xeltis has been selected as one of three finalists for the Swiss Medtech Awards. Stay tuned on June 12 to find out the winner; xeltis.com/news

account_circle